Complexo Hospitalario Universitario de Vigo-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2022

  1. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

  2. Progress in the quality of care for newly diagnosed people with HIV in Spain (2004–2019)

    Antiviral Therapy, Vol. 27, Núm. 4

2016

  1. Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir

    HIV Medicine, Vol. 17, Núm. 5, pp. 340-349

2015

  1. Cardiovascular risk factors and lifetime risk estimation in hiv-infected patients under antiretroviral treatment in Spain

    HIV Clinical Trials, Vol. 16, Núm. 2, pp. 57-65

2014

  1. Documento de consenso: Recomendaciones para el manejo de la enfermedad ósea metabólica en pacientes con virus de la inmunodeficiencia humana

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. 4, pp. 250-258

2011

  1. Alteraciones osteoarticulares en la infección por el VIH

    Enfermedades Infecciosas y Microbiologia Clinica

2009

  1. Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression

    Antiviral Therapy, Vol. 14, Núm. 2, pp. 195-201